Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
7 Patents
#2 in Vancouver, B.C.
#2,102 in unknown
Chemokine Therapeutics Corporation
Forward Citations = 38
12 inventors:
Chemokine Therapeutics Corporation
Calculating rank
% Expired Patents = 85.7
Forward Citations = 38
Loading Chart...
Loading Chart...
12 inventors (with patents filed for the assignee):
Hassan Salari (7 out of 20 patents)
Ahmed Merzouk (6 out of 25 patents)
Christopher R Tudan (5 out of 6 patents)
4. Geeta Saxena (5 out of 9 patents)
5. Connie J Eaves (2 out of 6 patents)
6. Lakhdar Arab (2 out of 2 patents)
7. Johanne Cashman (2 out of 2 patents)
8. Donald Wong (1 out of 3 patents)
9. Carolina Abramovich (1 out of 2 patents)
10. Mary A Richter, Legal Representative (1 out of 1 patent)
11. Michael Clark-Lewis, Legal Representative (1 out of 1 patent)
12. Ian Clark-Lewis (1 out of 7 patents)
7 patents:
Company Overview
Chemokine Therapeutics Corporation is a biotechnology company focused on developing novel treatments for cancer and other diseases. Their proprietary drug candidates target chemokine receptors to regulate immune responses and inhibit tumor growth. With a strong pipeline of innovative therapies, Chemokine aims to improve the lives of patients worldwide.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Chemokine Therapeutics Corporation. Retrieved from https://idiyas.com/company/chemokine-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]